Want to see HCAT full AI Analyst Report?
Health Catalyst (HCAT) Stock Forecast & Price Target
HCAT Analyst Ratings
HCAT Stock 12 Month Forecast
Average Price Target
$1.83▲(7.99% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Richard Close | Canaccord Genuity | $1.80 | hold | 6.51%Upside | Reiterated | 09/09/26 | ||
| David Larsen | BTIG | ― | hold | ― | Reiterated | 08/19/26 | ||
| Stan Berenshteyn | Wells Fargo | $1.75→$1.50 | hold | -11.24%Downside | Assigned | 08/13/26 | ||
| Daniel Grosslight | Citi | $2.50→$2 | hold | 18.34%Upside | Reiterated | 08/10/26 | ||
| David Grossman | Stifel Nicolaus | $2 | hold | 18.34%Upside | Reiterated | 08/07/26 | ||
| Ryan Daniels | William Blair | ― | buy | ― | Reiterated | 08/06/26 | ||
| Jessica Tassan | Piper Sandler | $2 | hold | 18.34%Upside | Reiterated | 05/12/26 | ||
| Jeffrey Garro | Stephens | $2→$1.75 | hold | 3.55%Upside | Reiterated | 05/12/26 | ||
| Sarah James | Cantor Fitzgerald | $3 | hold | 77.51%Upside | Reiterated | 05/08/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | $3 | hold | 77.51%Upside | Reiterated | 03/30/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Richard Close | 09/09/26 | $1.80 | hold | 6.51%Upside | Reiterated | Canaccord Genuity | ||
| David Larsen | 08/19/26 | ― | hold | ― | Reiterated | BTIG | ||
| Stan Berenshteyn | 08/13/26 | $1.75→$1.50 | hold | -11.24%Downside | Assigned | Wells Fargo | ||
| Daniel Grosslight | 08/10/26 | $2.50→$2 | hold | 18.34%Upside | Reiterated | Citi | ||
| David Grossman | 08/07/26 | $2 | hold | 18.34%Upside | Reiterated | Stifel Nicolaus | ||
| Ryan Daniels | 08/06/26 | ― | buy | ― | Reiterated | William Blair | ||
| Jessica Tassan | 05/12/26 | $2 | hold | 18.34%Upside | Reiterated | Piper Sandler | ||
| Jeffrey Garro | 05/12/26 | $2→$1.75 | hold | 3.55%Upside | Reiterated | Stephens | ||
| Sarah James | 05/08/26 | $3 | hold | 77.51%Upside | Reiterated | Cantor Fitzgerald | ||
| Elizabeth Anderson CFA | 03/30/26 | $3 | hold | 77.51%Upside | Reiterated | Evercore ISI |
Best Analysts Covering Health Catalyst
Copying Ryan Daniels's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -12.64% per trade.
Copying Ryan Daniels's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -32.07% per trade.
Copying Ryan Daniels's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -27.52% per trade.
HCAT Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 6 | 4 | 2 | 1 | 0 |
| Hold | 9 | 8 | 8 | 6 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 15 | 12 | 10 | 7 | 1 |
In the current month, HCAT has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HCAT average Analyst price target in the past 3 months is 1.83.
HCAT Financial Forecast
HCAT Earnings Forecast
Next quarter’s earnings estimate for HCAT is -$0.05 with a range of -$0.07 to -$0.02. The previous quarter’s EPS was $0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HCAT Sales Forecast
Next quarter’s sales forecast for HCAT is $55.39M with a range of $55.08M to $55.90M. The previous quarter’s sales results were $70.49M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
